NeOnc Technologies Holdings is trading 5.5% down at $4.43 after-hours on August 24, 2026, with no clear company-specific announcement or late-breaking catalyst identified.
- The stock is down from the regular-session close of $4.69.
- The latest significant news remains positive August 12 Phase 2a NEO100 glioma data, including 48.9% six-month progression-free survival versus a 20% benchmark; that announcement does not directly explain this drop.